HomeCompareSCTQ vs MRK

SCTQ vs MRK: Dividend Comparison 2026

SCTQ yields 5.45% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SCTQ wins by $13.49M in total portfolio value
10 years
SCTQ
SCTQ
● Live price
5.45%
Share price
$2.13
Annual div
$0.12
5Y div CAGR
66.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$13.55M
Annual income
$11,080,776.51
Full SCTQ calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — SCTQ vs MRK

📍 SCTQ pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSCTQMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SCTQ + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SCTQ pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SCTQ
Annual income on $10K today (after 15% tax)
$463.59/yr
After 10yr DRIP, annual income (after tax)
$9,418,660.03/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, SCTQ beats the other by $9,410,331.62/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SCTQ + MRK for your $10,000?

SCTQ: 50%MRK: 50%
100% MRK50/50100% SCTQ
Portfolio after 10yr
$6.80M
Annual income
$5,545,287.32/yr
Blended yield
81.50%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

SCTQ
No analyst data
Altman Z
5.4
Piotroski
4/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SCTQ buys
0
MRK buys
0
No recent congressional trades found for SCTQ or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSCTQMRK
Forward yield5.45%2.76%
Annual dividend / share$0.12$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR66.3%32.7%
Portfolio after 10y$13.55M$56.8K
Annual income after 10y$11,080,776.51$9,798.13
Total dividends collected$13.31M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: SCTQ vs MRK ($10,000, DRIP)

YearSCTQ PortfolioSCTQ Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$11,607$907.00$11,206$366.19+$401.00SCTQ
2$14,056$1,636.19$12,650$502.35+$1.4KSCTQ
3$18,119$3,079.47$14,407$694.19+$3.7KSCTQ
4$25,557$6,169.75$16,585$967.82+$9.0KSCTQ
5$40,872$13,525.48$19,342$1,363.89+$21.5KSCTQ
6$77,351$33,617.91$22,913$1,947.19+$54.4KSCTQ
7$181,648$98,882.80$27,662$2,823.89+$154.0KSCTQ
8$555,271$360,907.76$34,159$4,173.35+$521.1KSCTQ
9$2,308,805$1,714,665.39$43,337$6,308.80+$2.27MSCTQ
10$13,551,198$11,080,776.51$56,776$9,798.13+$13.49MSCTQ

SCTQ vs MRK: Complete Analysis 2026

SCTQStock

Spectra Systems Corporation invents, develops, and sells integrated optical systems in Rhode Island and internationally. It operates through three segments: Authentication Systems, Secure Transactions, and Banknote Cleaning. The company offers integrated solutions, including a system of taggant materials and sensor technology to authenticate banknotes that are used by central banks, as well as G7 country for passport security; banknote cleaning and disinfection systems that lifts sebum and other substances from the banknote through a dry process based on supercritical CO2 cleaning; and solutions to authenticate brand name products. It also provides optical materials for security and quality control, such as fluorescent and phosphorescent pigments and dyes, invisible pigments and dyes, and gasochromic response materials; customized materials and hardware solutions; and internal control systems used to verify the accuracy of transactions logged by providers of lottery and gaming operators. In addition, the company offers software and hardware systems comprising high-speed currency authentication sensors; quality control equipment for use in paper and polymer banknote manufacturing and printing; and security printers and hologram makers. The company was formerly known as Spectra Science Corporation and changed its name to Spectra Systems Corporation in June 2001. Spectra Systems Corporation was incorporated in 1996 and is headquartered in Providence, Rhode Island.

Full SCTQ Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this SCTQ vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SCTQ vs SCHDSCTQ vs JEPISCTQ vs OSCTQ vs KOSCTQ vs MAINSCTQ vs JNJSCTQ vs ABBVSCTQ vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.